tradingkey.logo

Meihua International Medical Technologies Co Ltd

MHUA

0.395USD

+0.026+6.99%
Market hours ETQuotes delayed by 15 min
12.51MMarket Cap
--P/E TTM

Meihua International Medical Technologies Co Ltd

0.395

+0.026+6.99%
More Details of Meihua International Medical Technologies Co Ltd Company
Meihua International Medical Technologies Co Ltd is a holding company mainly engaged in the research, development, manufacturing and sales of Class I, Class II and Class III disposable medical devices. The Company's products include self-manufactured and out-sourced products. Class I disposable medical devices include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene (LDPE) bottles for eye drops, high-density polyethylene (HDPE) bottles for tablets, and others. Class II disposable medical devices include disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, and others. Class III disposable medical devices include disposable infusion pumps, anesthesia puncture kits, electronic pumps, and others.
Company Info
Ticker SymbolMHUA
Company nameMeihua International Medical Technologies Co Ltd
IPO dateFeb 16, 2022
CEOMr. Yulin Wang
Number of employees619
Security typeOrdinary Share
Fiscal year-endFeb 16
Address88 Tongda Road, Touqiao Town, Guangling District
CityYANGZHOU
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code225000
Phone8651489800199
Websitehttps://meihuamed.com/
Ticker SymbolMHUA
IPO dateFeb 16, 2022
CEOMr. Yulin Wang
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Yongjun Liu
Mr. Yongjun Liu
Chairman of the Board
Chairman of the Board
15.94M
--
Mr. Yulin Wang
Mr. Yulin Wang
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Xiaoming E
Mr. Xiaoming E
Independent Director
Independent Director
--
--
Mr. Xu Han
Mr. Xu Han
Independent Director
Independent Director
--
--
Mr. Wenzhang Jia
Mr. Wenzhang Jia
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Yongjun Liu
Mr. Yongjun Liu
Chairman of the Board
Chairman of the Board
15.94M
--
Mr. Yulin Wang
Mr. Yulin Wang
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Xiaoming E
Mr. Xiaoming E
Independent Director
Independent Director
--
--
Mr. Xu Han
Mr. Xu Han
Independent Director
Independent Director
--
--
Mr. Wenzhang Jia
Mr. Wenzhang Jia
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Resales of Sourced Disposable Medical Devices from Third Party Manufacturers
49.30M
50.88%
Self-Manufactured Products
47.61M
49.12%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Resales of Sourced Disposable Medical Devices from Third Party Manufacturers
49.30M
50.88%
Self-Manufactured Products
47.61M
49.12%
Shareholding Stats
Updated: Sun, Feb 23
Updated: Sun, Feb 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Liu (Yongjun)
49.95%
Citadel Advisors LLC
0.47%
UBS Financial Services, Inc.
0.27%
Two Sigma Investments, LP
0.09%
Jane Street Capital, L.L.C.
0.08%
Other
49.14%
Shareholders
Shareholders
Proportion
Liu (Yongjun)
49.95%
Citadel Advisors LLC
0.47%
UBS Financial Services, Inc.
0.27%
Two Sigma Investments, LP
0.09%
Jane Street Capital, L.L.C.
0.08%
Other
49.14%
Shareholder Types
Shareholders
Proportion
Individual Investor
49.95%
Hedge Fund
0.60%
Investment Advisor
0.27%
Research Firm
0.09%
Venture Capital
0.06%
Investment Advisor/Hedge Fund
0.05%
Other
48.99%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
14
16.27M
51.01%
-2.20M
2025Q1
18
16.27M
51.01%
-2.22M
2024Q4
19
16.19M
50.75%
-2.28M
2024Q3
18
18.39M
58.65%
+1.61M
2024Q2
17
16.65M
52.69%
+166.88K
2024Q1
18
16.39M
51.82%
+107.48K
2023Q4
16
16.23M
51.17%
+182.79K
2023Q3
13
15.99M
66.79%
-24.95K
2023Q2
13
15.96M
66.67%
-82.11K
2023Q1
12
16.02M
66.91%
+15.14K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Liu (Yongjun)
15.94M
49.95%
--
--
Dec 31, 2024
Citadel Advisors LLC
150.52K
0.47%
+150.52K
--
Mar 31, 2025
UBS Financial Services, Inc.
86.27K
0.27%
+23.99K
+38.53%
Mar 31, 2025
Two Sigma Investments, LP
27.83K
0.09%
-14.18K
-33.75%
Mar 31, 2025
Jane Street Capital, L.L.C.
26.50K
0.08%
+1.33K
+5.27%
Mar 31, 2025
XTX Markets LLC
19.00K
0.06%
-15.93K
-45.62%
Mar 31, 2025
Geode Capital Management, L.L.C.
14.39K
0.05%
--
--
Mar 31, 2025
Renaissance Technologies LLC
12.40K
0.04%
+12.40K
--
Mar 31, 2025
Morgan Stanley & Co. LLC
2.79K
0.01%
--
--
Mar 31, 2025
Virtu Americas LLC
--
0%
-41.36K
-100.00%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI